File:Endothelial dysfunction MECFS.png

Summary[edit | edit source]

Title: (or description)[edit | edit source]

Endothelial dysfunction, identified by a signicantly reduced reactive hyperaemia index (RHI), in ME/CFS patients meeting the Canadian Consensus Criteria, but improved with immunoadsorption treatment. Endothelial dysfunction is an established risk factor for cardiovascular disease and was associated with disease severity and severity of immune symptoms.

Author: (or citation)[edit | edit source]

Scherbakov, N., Szklarski, M., Hartwig, J., Sotzny, F., Lorenz, S., Meyer, A., Grabowski, P., Doehner, W., and Scheibenbogen, C. (2020). Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome. ESC Heart Failure 7: 1064–1071.

Source: (e.g. internet address)[edit | edit source]

Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome (2020)

Other information:[edit | edit source]

• List of abnormal findings in chronic fatigue syndrome and myalgic encephalomyelitis

Licensing[edit | edit source]

This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 International license. CC-BY-NC-4.0 Creative Commons Attribution-NonCommercial 4.0 International truetrue You are free: to share – to copy, redistribute and transmit the work Under the following conditions: attribution – You must attribute the work in the manner specified by the author or licensor (but not in any way that suggests that they endorse you or your use of their work). noncommercial — You may not use the material for commercial purposes. https://creativecommons.org/licenses/by-nc/4.0/ CC BY NC 4.0 International Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) truetrue